What Does Ziopharm Oncology Do?

Total employees0
HeadquartersHouston
Founded2003

Ziopharm Oncology, Inc., which rebranded to Alaunos Therapeutics, Inc. (NASDAQ: TCRT) in January 2022, was a clinical-stage biopharmaceutical company. It focused on developing T-cell receptor (TCR) therapies for cancer, aiming to harness the power of the immune system to target and destroy solid tumors. The company utilized a non-viral T-cell engineering platform called Sleeping Beauty. Following strategic challenges and restructuring efforts, Alaunos Therapeutics filed for Chapter 7 bankruptcy in October 2023 and ceased operations.

Where Is Ziopharm Oncology's Headquarters?

Ziopharm Oncology officeZiopharm Oncology officeZiopharm Oncology officeZiopharm Oncology office
*Images sourced via web search. Rights belong to original owners

HQ Function

Served as the primary corporate office, overseeing administrative, research coordination, and strategic operations before cessation of activities.

Notable Features:

Likely standard office space within a commercial office park, equipped for administrative and executive functions. Specific architectural details are not widely publicized.

Work Culture:

Prior to its difficulties, the culture likely emphasized scientific innovation, collaboration, and a fast-paced environment typical of clinical-stage biotech companies focused on oncology.

HQ Significance:

The Houston headquarters marked a shift from its previous Boston base (as Ziopharm) and was intended to be the hub for its renewed focus under the Alaunos brand. It was central to its operational and strategic leadership before the company's dissolution.

Values Reflected in HQ: Prior to ceasing operations, the HQ would have aimed to reflect values such as innovation in cancer therapy, scientific rigor, and a commitment to developing new treatments for patients.

Location:

The company's operations were primarily based in the United States, focusing on research, development, and clinical trials. While clinical trials may have involved international sites, it did not maintain significant independent global office infrastructure. Its primary focus markets and operational activities were within the U.S.

Street Address:

11000 Equity Drive, Suite 150

City:

Houston

State/Province:

TX

Country:

USA

Where Else Does Ziopharm Oncology Operate Around the World?

Boston, Massachusetts, USA

Address: One First Avenue, Parris Building #34, Navy Yard Plaza, Boston, MA 02129 (Former Ziopharm HQ)

Focused on research and development, corporate strategy, and leveraging the dense network of academic institutions, hospitals, and biotech companies in the Greater Boston area.

Buying Intent Signals for Ziopharm Oncology

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ziopharm Oncology? Meet the Executive Team

As of April 2025, Ziopharm Oncology' leadership includes:

Robert Postma - Former President and Chief Executive Officer (led through bankruptcy)
Michael Wach - Former EVP and Chief Financial Officer
Abhishek Srivastava - Former SVP, Technical Operations

Who's Investing in Ziopharm Oncology?

Ziopharm Oncology has been backed by several prominent investors over the years, including:

MSD Global Health Innovation Fund (Merck)
WaterMill Asset Management Corp.
TriArmenia Cooperatief U.A.
BlackRock
The Vanguard Group

What Leadership Changes Has Ziopharm Oncology Seen Recently?

Hire1
Exits2

The 12 months leading to and including the bankruptcy in October 2023 saw significant executive turnover as the company navigated severe financial distress, restructuring efforts, and ultimately ceased operations. Most executives departed as part of this process.

Departures

Kevin S. Boyle, Sr., Kevin S. Boyle, Sr. departed as President and CEO amid company restructuring.
Michael Wach, Michael Wach's role concluded with the company's Chapter 7 bankruptcy filing and cessation of operations.

New Appointments:

Robert Postma, Robert Postma was appointed President and CEO to lead the company through its strategic review and subsequent processes.

What Technology (Tech Stack) Is Used byZiopharm Oncology?

Discover the tools Ziopharm Oncology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ziopharm Oncology Email Formats and Examples

Companies like Alaunos Therapeutics typically use common email formats. While no longer operational, a common format observed for biotech companies is [first_initial][last]@[companydomain].com.

[first_initial][last]@alaunos.com

Format

jdoe@alaunos.com

Example

0%

Success rate

What's the Latest News About Ziopharm Oncology?

Fierce BiotechOctober 25, 2023

Alaunos Therapeutics news title: Alaunos Therapeutics files for Chapter 7 bankruptcy, ends quest for TCR T-cell glory

Alaunos Therapeutics has filed for Chapter 7 bankruptcy and will cease operations. The decision follows a strategic review initiated earlier in the year, during which the company explored various alternatives, including partnerships or a sale....more

PR Newswire (Company Press Release)June 6, 2023

Alaunos Therapeutics news title: Alaunos Therapeutics Appoints Robert Postma as President and Chief Executive Officer

Alaunos Therapeutics announced the appointment of Robert Postma as its new President and Chief Executive Officer, effective immediately. Mr. Postma succeeded Kevin S. Boyle, Sr., who departed the company....more

GlobeNewswire (Company Press Release)January 26, 2022

Ziopharm Oncology news title: Ziopharm Oncology Becomes Alaunos Therapeutics

Ziopharm Oncology, Inc. announced it has changed its name to Alaunos Therapeutics, Inc. The change reflects the company's evolution and its focus on developing T-cell receptor (TCR) therapies....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ziopharm Oncology, are just a search away.